Photo CHUB
FRNLEN

>>Aperçu des publications scientifiques du Prof. André EFIRA

André EFIRA

1: Sins JWR, Fijnvandraat K, Rijneveld AW, Boom MB, Kerkhoffs JH, van Meurs AH, de Groot MR, Heijboer H, Dresse MF, Lê PQ, Hermans P, Vanderfaeillie A, Van Den Neste EW, Benghiat FS, Kesse-Adu R, Delannoy A, Efira A, Azerad MA, de Borgie CA, Biemond BJ. Effect of N-acetylcysteine on pain in daily life in patients with sickle cell disease: a randomised clinical trial. Br J Haematol. 2017 Jun 23. doi: 10.1111/bjh.14809. [Epub ahead of print]
>PubMed

2: Van Obbergh F, Knoops L, Devos T, Beguin Y, Graux C, Benghiat F, Kargar-Samani K, Bauwens D, Efira A, Dubois C, Springael C, Montfort L, Connerotte T, Capron A, Delannoy A, Wallemacq P. The clinical relevance of imatinib plasma trough concentrations in chronic myeloid leukemia. A Belgian study. Clin Biochem. 2017 May;50(7-8):452-454. doi: 10.1016/j.clinbiochem.2016.12.006. Epub 2016 Dec 22.
>PubMed

3: Lê PQ, Gulbis B, Dedeken L, Dupont S, Vanderfaeillie A, Heijmans C, Huybrechts S, Devalck C, Efira A, Dresse MF, Rozen L, Benghiat FS, Ferster A. Survival among children and adults with sickle cell disease in Belgium: Benefit from hydroxyurea treatment. Pediatr Blood Cancer. 2015 Nov;62(11):1956-61. doi: 10.1002/pbc.25608. Epub 2015 Jul 14.
>PubMed

4: Delforge M, Selleslag D, Beguin Y, Triffet A, Mineur P, Theunissen K, Graux C, Trullemans F, Boulet D, Van Eygen K, Noens L, Van Steenweghen S, Lemmens J, Pierre P, D'hondt R, Ferrant A, Deeren D, Van De Velde A, Wynendaele W, André M, De Bock R, Efira A, Breems D, Deweweire A, Geldhof K, Pluymers W, Harrington A, MacDonald K, Abraham I, Ravoet C. Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients with lower risk myelodysplastic syndromes. Leuk Res. 2014 May;38(5):557-63. doi: 10.1016/j.leukres.2014.02.003. Epub 2014 Feb 14.
>PubMed

5: Efira A, Azerad MA. [Refractory anemias]. Rev Med Brux. 2013 Sep;34(4):323-7. Review. French.
>PubMed

6: El Kenz H, Efira A, Le PQ, Thiry C, Valsamis J, Azerad MA, Corazza F. Transfusion support of autoimmune hemolytic anemia: how could the blood group genotyping help? Transl Res. 2014 Jan;163(1):36-42. doi: 10.1016/j.trsl.2013.09.007. Epub 2013 Oct 9.
>PubMed

7: Bleiberg H, Vandebroek A, Deleu I, Vergauwe P, Rezaei Kalantari H, D'Haens G, Paesmans M, Peeters M, Efira A, Humblet Y. A phase II randomized study of combined infusional leucovorin sodium and 5- FU versus the leucovorin calcium followed by 5-FU both in combination with irinotecan or oxaliplatin in patients with metastatic colorectal cancer. Acta Gastroenterol Belg. 2012 Mar;75(1):14-21.
>PubMed

8: Debaugnies F, Azerad MA, Noubouossié D, Rozen L, Hemker HC, Corazza F, Efira A, Demulder A. Evaluation of the procoagulant activity in the plasma of cancer patients using a thrombin generation assay. Thromb Res. 2010 Dec;126(6):531-5. doi: 10.1016/j.thromres.2010.09.002. Epub 2010 Sep 25.
>PubMed

9: Mendes da Costa P, Efira A. [May still in 2010 a surgeon decide alone to operate a digestive cancer?]. Rev Med Brux. 2009 Nov-Dec;30(6):549-54. French.
>PubMed

10: Civrilli K, Damry N, Steppé R, Efira A, Mathieu J. Bilateral adrenal myelolipomas. JBR-BTR. 2008 May-Jun;91(3):90-1.
>PubMed

11: Schandené L, Roufosse F, de Lavareille A, Stordeur P, Efira A, Kennès B, Cogan E, Goldman M. Interferon alpha prevents spontaneous apoptosis of clonal Th2 cells associated with chronic hypereosinophilia. Blood. 2000 Dec 15;96(13):4285-92.
>PubMed

12: Efira A. [What is the role of internal medicine in the collective of a general hospital?]. Acta Clin Belg. 2000 Jul-Aug;55(4):199-204. French.
>PubMed

13: Roufosse F, Schandené L, Sibille C, Willard-Gallo K, Kennes B, Efira A, Goldman M, Cogan E. Clonal Th2 lymphocytes in patients with the idiopathic hypereosinophilic syndrome. Br J Haematol. 2000 Jun;109(3):540-8.
>PubMed

14: Roufosse F, Schandené L, Sibille C, Kennes B, Efira A, Cogan E, Goldman M. T-cell receptor-independent activation of clonal Th2 cells associated with chronic hypereosinophilia. Blood. 1999 Aug 1;94(3):994-1002.
>PubMed

15: Plein D, Van Camp G, Efira A, Brunet A, Vandenbossche JL. Intracardiac thrombi associated with antiphospholipid antibodies. J Am Soc Echocardiogr. 1996 Nov-Dec;9(6):891-3.
>PubMed

16: des Grottes JM, Bouvry P, Cantinieaux B, Efira A. [A case of thrombotic thrombopenic purpura. Literature review]. Rev Med Brux. 1996 Jun;17(3):136-9. Review. French.
>PubMed

17: Postelmans L, Verougstraete C, Libert J, Efira A, Caspers-Velu L. [Intravenous corticosteroid megadose treatment in ocular Behçet disease]. Bull Soc Belge Ophtalmol. 1996;262:95-103. French.
>PubMed

18: Volz A, Renard N, Alame T, Efira A. [Churg-Strauss syndrome: personnel case report and literature review]. Rev Med Brux. 1994 Mar-Apr;15(2):76-9. Review. French.
>PubMed

19: Cauchie P, Delwiche F, Efira A, Vincken W, Volckaert A, Decaux G. Tuberculosis: cause of death in Brussels. Ann Med Interne (Paris). 1988;139(2):132-3.
>PubMed

!Données extraites de PubMed et filtrées pour limiter les risques d'homonymie. Vous pouvez supprimer le filtre "Brugmann" afin d'élargir les résultats.

>>Consulter la fiche d'identité du Prof. André EFIRA.